Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
RESEARCH TOOLSreports
Holding XERS?
Track your performance easily
| Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 48.32M | - | $ 33.20M | $ 33.14M | $ 29.73M |
| Gross Profit | $ 40.12M | - | $ 33.20M | $ 26.85M | $ 24.46M |
| EBIT | $ -5.68M | - | $ -10.62M | $ -8.90M | $ -18.18M |
| EBITDA | $ -2.32M | - | $ -7.27M | $ -5.40M | $ -15.11M |
| Net Income Common Stockholders | $ -12.19M | - | $ -16.83M | $ -12.93M | $ -21.83M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 65.97M | $ 80.67M | $ 95.10M | $ 121.97M | $ 93.43M |
| Total Assets | $ 327.78M | $ 328.78M | $ 321.36M | $ 344.52M | $ 303.02M |
| Total Debt | $ 227.94M | $ 224.99M | $ 198.42M | $ 198.06M | $ 138.51M |
| Net Debt | $ 161.97M | $ 144.32M | $ 103.31M | $ 76.09M | $ 45.07M |
| Total Liabilities | $ 323.92M | $ 315.14M | $ 291.31M | $ 299.33M | $ 247.98M |
| Stockholders Equity | $ 3.87M | $ 13.69M | $ 30.05M | $ 45.19M | $ 55.04M |
| Cash Flow | - | ||||
| Free Cash Flow | - | - | $ -26.38M | $ -16.25M | $ -17.93M |
| Operating Cash Flow | - | - | $ -26.14M | $ -16.12M | $ -17.75M |
| Investing Cash Flow | - | - | $ -43.98M | $ 9.17M | $ 6.71M |
| Financing Cash Flow | - | - | $ -863.00K | $ 49.16M | $ -187.00K |